Folgen
Dr. Sebak Datta
Dr. Sebak Datta
Senior Research Scientist, TCG Lifesciences Pvt. Ltd.
Bestätigte E-Mail-Adresse bei tcgls.com
Titel
Zitiert von
Zitiert von
Jahr
In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors
P Tymoszuk, H Evens, V Marzola, K Wachowicz, MH Wasmer, S Datta, ...
European journal of immunology 44 (8), 2247-2262, 2014
1312014
Lapatinib and doxorubicin enhance the S tat1‐dependent antitumor immune response
L Hannesdóttir, P Tymoszuk, N Parajuli, MH Wasmer, S Philipp, N Daschil, ...
European journal of immunology 43 (10), 2718-2729, 2013
1282013
Lin28b controls a neonatal to adult switch in B cell positive selection
S Vanhee, H Åkerstrand, TA Kristiansen, S Datta, G Montano, S Vergani, ...
Science immunology 4 (39), eaax4453, 2019
252019
Replenishment of the B cell compartment after doxorubicin-induced hematopoietic toxicity is facilitated by STAT1
S Datta, N Parajuli, P Tymoszuk, E Ottina, W Parson, R Sgonc, A Villunger, ...
Journal of Leukocyte Biology 95 (6), 853-866, 2014
72014
Structure‐based discovery of (S)‐2‐amino‐6‐(4‐fluorobenzyl)‐5,6,11,11a‐tetrahydro‐1H‐imidazo[1′,5′:1,6]pyrido[3,4‐b]indole‐1,3(2H)‐dione as low …
A Roy, T Sarkar, S Datta, A Maiti, M Chakrabarti, T Mondal, C Mondal, ...
Chemical Biology & Drug Design 99 (3), 496-503, 2022
22022
Novel role of STAT1 in the recovery from doxorubicin induced immuno‐suppression
N Parajuli, S Datta, S Pohle, A Villunger, JB Koller, L Hannesdóttir, V Labi, ...
The FASEB Journal 24, 966.5-966.5, 2010
2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–6